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It is widely accepted that the growth and regeneration of tissues and organs is tightly controlled. Although
experimental studies are beginning to reveal molecular mechanisms underlying such control, there is still very little
known about the control strategies themselves. Here, we consider how secreted negative feedback factors
(‘‘chalones’’) may be used to control the output of multistage cell lineages, as exemplified by the actions of GDF11
and activin in a self-renewing neural tissue, the mammalian olfactory epithelium (OE). We begin by specifying
performance objectives—what, precisely, is being controlled, and to what degree—and go on to calculate how well
different types of feedback configurations, feedback sensitivities, and tissue architectures achieve control. Ultimately,
we show that many features of the OE—the number of feedback loops, the cellular processes targeted by feedback,
even the location of progenitor cells within the tissue—fit with expectations for the best possible control. In so doing,
we also show that certain distinctions that are commonly drawn among cells and molecules—such as whether a cell is a
stem cell or transit-amplifying cell, or whether a molecule is a growth inhibitor or stimulator—may be the
consequences of control, and not a reflection of intrinsic differences in cellular or molecular character.
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Introduction
In recent decades, biologists have come to view cell lineages
as fundamental units of tissue and organ development,
maintenance, and regeneration. The highly differentiated,
often nondividing cells that characterize the mature func-
tions of tissues are seen as end products of orderly, tissue-
speciﬁc sequences of cell divisions, during which progenitor
cells pass through distinct stages, marked by expression of
stage-speciﬁc genes (e.g., [1–4]). At the starting points of
lineages—particularly those in self-renewing tissues such as
blood, epidermis, and the intestinal lining—one ﬁnds stem
cells, characterized both by multipotency (ability to produce
many cell types) and their ability to maintain their own
numbers through self-replication [5–8]. As scientists and
clinicians have become increasingly interested in harnessing
these features of stem cells to repair injury and cure disease,
there has been a resurgence of interest in the mechanisms
underlying the execution and regulation of cell lineages (e.g.,
[9–12]).
The functions of lineages are often presented in terms of
progressive allocation of developmental potential: Thus,
pluripotent stem cells often give rise to oligopotent progen-
itors, which in turn give rise to unipotent (committed)
progenitors. The sequential expression of marker genes at
different lineage stages may be related to transcriptional
‘‘priming’’ events needed to lock cells into speciﬁc patterns of
gene expression [13,14].
Not all lineage stages correlate with restriction of cell fate,
however, raising the question of what else lineages do. The
fact that lineage intermediates often display ‘‘transit-amplify-
ing’’ behavior, i.e., are capable of at least some degree of self-
replication, has led to the suggestion that lineage stages play
essential roles in the control of tissue and organ growth (with
growth referring in this case to increase in cell number).
Here, we seek to discover what those roles are. We approach
this question from the perspective of lineages in general, and
within the context of the mammalian olfactory epithelium
(OE), the neural tissue that senses odor and transmits
olfactory information to the brain. The OE is a continually
self-renewing tissue, even in man, and is capable of rapid
regeneration [15]. As discussed below, a wealth of exper-
imental data on the OE lineage and the molecules that
regulate it makes the OE an attractive system in which to
investigate the relationship between lineages and growth
control.
Performance Objectives of Growing Tissues
In biology, ‘‘control’’ is often used interchangeably with
‘‘regulation,’’ but in engineering, control has a precise
meaning: It refers to the strategies that enable a system to
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PLoS BIOLOGYachieve desired ends, usually in a robust manner. To begin
talking about the control needs of growing tissues and organs,
we must ﬁrst ask what are the ‘‘desired’’ ends, and to what
kinds of uncertainties and perturbations must growth and
differentiation be robust?
Perhaps the most obvious objective of a growth control
system is to reach and maintain a speciﬁed size. Sizes of
organs such as the brain, for example, are genetically
speciﬁed within narrow tolerances (e.g., [16]). Moreover,
self-renewing organs, such as the liver, seem to ‘‘remember’’
their appropriate sizes, as they accurately regenerate to their
original sizes following even massive lesions [17]. The fact that
many genetic alterations can affect ﬁnal organ size (e.g.,
[18,19]) suggests that there are diverse molecular pathways by
which size may be regulated.
A less obvious performance objective is control of growth
rate. Consider, for example, a self-renewing tissue that
maintains constant size by balancing continual cell death
with cell production. Following an injury in which differ-
entiated cells are destroyed, if there is no adjustment in cell
production, those cells will be replaced only at the same
(often very slow) rate at which they previously turned over. In
regenerating tissues, however, it is common to observe a
dramatic increase in proliferation following injuries, with
rapid restoration of tissue morphology and size [17,20,21].
Even in tissues that do not regenerate, control of growth rate
is likely to be important during development, so that the
changing sizes of different organs are properly coordinated
with each other.
Other possible targets of control are the proportions of cell
types in a tissue. For example, in a branched lineage (one with
more than one terminal-stage cell type) a ﬁxed ratio of end
products may be important for tissue or organ function [22].
In lineages that operate continuously, it may also be desirable
to ensure that stem and progenitor cells (which do not usually
contribute directly to tissue function) are not too great a
fraction of the tissue mass.
How difﬁcult should it be for tissues to achieve such
objectives? With control, the difﬁculty of the task depends
upon the magnitude of the perturbations that are normally
encountered (e.g., genetic and/or random effects on cell
behavior, environmental ﬂuctuations, injury, and disease); the
sensitivity of the system’s behavior to those perturbations;
and the level of imprecision in output that is acceptable.
In recent years, increasing attention has been focused on
the control challenges of biological networks, including those
associated with metabolism, intracellular signaling, and gene
regulation (e.g., [23–26]). Superﬁcially, cell lineages look a
great deal like these other kinds of pathways (Figure 1). Yet
the components of lineages—cell stages—do not just transmit
signals or material from one to another; they typically
undergo autonomous, exponential expansion at the same
time. This imparts a characteristic volatility to lineage
dynamics that no doubt poses challenges for control. Given
such challenges, it would not be surprising if the control of
tissue and organ growth necessitates control strategies unlike
those encountered elsewhere in biology. Here, we take steps
toward identifying such strategies.
Results
Lineage Dynamics in the Absence of Control
One way to identify the control needs of a system, and the
strategies that may be used to address those needs, is to build
models and explore their behavior. Figure 2A is a general
representation of an unbranched cell lineage that begins with
a pool of stem cells, ends with a postmitotic cell type, and
possesses any number of transit-amplifying progenitor stages.
If cells at each stage are numerous, and divisions asynchro-
nous, then the behavior of such a system over time can be
Figure 1. Biological Pathways That Are Potential Targets of Control
Like metabolic, signaling, and gene expression pathways, cell lineages
may be viewed as input–output pathways in which information or
material flows through a series of defined elements (A–D) at rates
controlled by measurable parameters (e.g., enzyme levels E1, E2, synthesis
rates v1, v2, etc.). Unlike these other pathways, cell lineages are
characterized by a potential for exponential expansion at most or all
stages (parameters p0, p1, etc.). The impact of this difference on the
strategies that may be used for tissue growth control has been little
studied.
doi:10.1371/journal.pbio.1000015.g001
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Author Summary
Many tissues and organs grow to precise sizes and, when injured,
regenerate accurately and rapidly. Here, we ask whether the
organization of cells into lineages, and the feedback interactions
that occur within lineages, are necessary elements of control
strategies that make such behavior possible. Drawing on mathe-
matical modeling and the results of experimental manipulation of
the mouse olfactory epithelium, we show that performance
objectives, such as robust size specification, fast regeneration from
a variety of initial conditions, and maintenance of high ratios of
differentiated to undifferentiated cells, can be simultaneously
achieved through a combination of lineage structures, signaling
mechanisms, and spatial distributions of cell types that correspond
well with what is observed in many growing and regenerating
tissues. Key to successful control is an integral-feedback mechanism
that is implemented when terminally differentiated cells secrete
molecules that lower the probability that progenitor cells replicate
versus differentiate. Interestingly, this mechanism also explains how
the distinctive proliferative behaviors of stem cell and ‘‘transit-
amplifying’’ cell populations can emerge as a consequence of
feedback effects, rather than intrinsic programming of cell types.represented by a system of ordinary differential equations
(Figure 2B) with two main classes of parameters. The v-
parameters quantify how rapidly cells divide at each lineage
stage (in particular, v¼ln2/k, where k¼the duration of a cell
cycle). The p-parameters quantify the fraction of the progeny
of any lineage stage that remains at the same stage (i.e., 1-p is
the fraction that differentiates into cells of the next stage).
Thus p may be thought of as an ampliﬁcation, or replication,
probability. As each lineage stage has its own v and p, we use
subscripts to distinguish them.
Let us refer to the number of terminal-stage cells at any
point in time as the output of a lineage system. From Figure
2B, we can see that a system is not stable—over time the
output increases without bound—if pi . 0.5 for any i.I n
contrast, if pi , 0.5 for all i, stem and progenitor cells
eventually run out, and the production of new terminal-stage
cells stops. Provided terminal-stage cells do not die at an
appreciable rate, such a system will reach a ﬁnal state with a
ﬁxed number of terminal-stage cells. Finally, if p0¼0.5, and pi
, 0.5 for i . 0, then the system will eventually produce
terminal-stage cells at a constant rate. If such cells die or are
shed with a constant probability per unit time (represented in
Figure 2B by the rate constant d), then the output will
approach a steady state, the solution for which is given in
Figure 2C (solutions for certain cases of ﬁnal-state behavior
are also given in Protocols S1–S3, sections 5 and 6).
The result in Figure 2C describes a steady state that is quite
sensitive to the system’s parameters. For example, output is
proportional to the number of stem cells (v0, which remains
constant at its initial value) and the rate of stem cell division
(v0), and inversely proportional to the rate of terminal-stage
cell death (d). Output varies even more sensitively with the pi.
For example, increasing the value of a pi from 0.45 to 0.4725—
a 5% change—necessarily produces a 74% increase in the
output of terminally differentiated cells. In engineering,
parameter sensitivity is usually quantiﬁed as the fold change
in output for a given fold change in the parameter (equivalent
to the slope of a log-log plot of output vs. parameter). Thus, a
linear relationship corresponds to a sensitivity of 1 (directly
proportional) or 1 (inversely proportional). From Figure 2C,
we may calculate that the sensitivity of the output to any pi is
pi/(1   3pi þ 2pi
2), which for pi , 0.5 is always greater than 1,
and grows without bound as pi approaches 0.5.
In well-regulated biological systems, parameter sensitivities
  1 tend to be undesirable, since genetic or environmental
variability can easily cause several-fold changes in the
biological processes (levels of proteins, cell growth rates,
etc.) that underlie parameters [27–29]. A system that cannot
compensate for such variation is justiﬁably considered fragile
(the opposite of robust).
Arguably, the most severe fragility of the system in Figure 2
is the constraint placed on the stem cell replication
probability: p0 must be exactly 0.5 for a non-zero steady state
to exist (effectively, the system’s sensitivity to p0 is inﬁnite).
This is simply another way of stating that, unless exactly half
of all stem cell progeny are stem cells, lineages eventually
Figure 2. Lineage Behavior in the Absence of Control
(A) Cartoon of an unbranched lineage that begins with a stem cell (type 0), progresses through an arbitrary number of transit-amplifying stages (types1
to n 1) and ends with a postmitotic terminal-stage cell (type n). Parameters vi and pi are the rate constants of cell cycle progression and the replication
probabilities, respectively, for each stage. Turnover of the terminal-stage cell is represented with a cell-death rate constant, d.
(B) Representation of the cell lineage shown in (A), as a system of ordinary differential equations. In these equations, vi(t) stands for the number (or
concentration) of cells of type i at time t, with each equation expressing the rate of expansion (or contraction) of each cell type. For all cell types except
the first and last, this rate is the sum of two terms: production by cells of the previous lineage stage, and net production (or loss) due to replication (or
differentiation) of cells at the same lineage stage. For the first cell type, there is no production from a prior stage, and for the last cell type, loss due to
cell death is included.
(C) Steady state solution for the output (number of terminal-stage cells) of the general system of equations given in (B). Notice that this output is
linearly, or more than linearly, sensitive to every system parameter, with the exception of the vi for i . 0, which do not appear in the solution.
doi:10.1371/journal.pbio.1000015.g002
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achieved by having every stem cell undergo perfect asym-
metric divisions, but that does not seem to be what normally
happens. Rather, individual stem cells behave stochastically,
sometimes giving rise to two, one, or zero stem cells (e.g.,
[6,8,30]). For the exact condition p0 ¼ 0.5 to arise as a
population average, when such behavior is not a cell
autonomous imperative, is an extraordinary—and yet poorly
understood—feature of stem cell systems.
Feedback Control of Transit-Amplifying Cells: Insights
from the Olfactory Epithelium
The idea that negative feedback is used to regulate tissue
size and enhance regeneration is an old one. Over 40 y ago,
Bullough [31] introduced the term chalone to refer to secreted
factors that inhibit growth of the tissues and organs that
secrete them. When a tissue is injured or partially removed,
reduction in chalone levels would thus result in an up-
regulation of tissue production. The view that chalones are
secreted factors was supported by in vitro experiments, and
by experiments with parabiotically joined pairs of animals in
which partial hepatectomy in one animal led to liver cell
proliferation in the other [32].
Although many of the original, in vitro–deﬁned chalones
have yet to be fully characterized, genetic studies in the 1990s
demonstrated that growth and differentiation factor 8
(GDF8)/myostatin (Mstn1,M G I : 9 5 6 9 1 ) ,am e m b e ro ft h e
transforming growth factor b (TGFb) superfamily of secreted
signaling molecules, is speciﬁcally expressed by striated
muscle cells (the terminal-stage cells of muscle lineages),
inhibits the production of muscle, and when genetically
eliminated from animals, results in the production of super-
numerary muscle cells and an increase in muscle mass [33].
Subsequently, GDF11 (MGI:1338027)—a close relative of
GDF8—was shown to be produced speciﬁcally by cells of
the neuronal lineage of the mouse OE, and to provide
feedback to inhibit the production of neurons (olfactory
receptor neurons; ORNs) in that system [34]. Animals
deﬁcient in GDF11 also develop supernumerary ORNs. In
recent years, factors that exert negative feedback on growth
have been described for many other tissues, including skin,
liver, bone, brain, blood cells, retina, and hair (Table S1).
Many of these factors turn out to be members of the TGFb
superfamily, especially the TGFb/activin branch of that
superfamily [35].
The OE of the mouse is a particularly useful system for
studying lineage progression and feedback: It is continually
self-renewing; its lineage stages are well deﬁned; its cells can
be studied in tissue culture; and it can be manipulated in vivo
through genetic, chemical, or surgical means [36–38]. The OE
neuronal lineage consists of a stem cell (which expresses Sox2
[MGI: 98364], a gene encoding an SRY-box transcription
factor), that gives rise to cells that express the proneural gene
Mash1 (Ascl1, MGI: 96919), which in turn give rise to cells that
express another proneural gene, Neurogenin1 (Ngn1; Neurog1;
MGI: 107754), which in turn give rise to cells that exit the cell
cycle and differentiate into ORNs. Recent data have raised
the possibility that the Sox2
þ and Mash1
þ stages are not truly
distinct, but rather are interchangeable states of the stem cell
(K. K. Gokoffski et al., unpublished data). However, the Ngn1
þ
cell—which is usually referred to as the Immediate Neuronal
Precursor, or INP—is clearly a distinct transit-amplifying cell
stage (Figure 3A; [34,39,40]).
The INP appears to give rise solely to ORNs, i.e., it does not
represent a lineage branch point [39]. It is therefore
interesting that the feedback actions of GDF11 seem to be
directed speciﬁcally at INPs [34]: In vitro, GDF11 completely,
but reversibly, arrests INP divisions, yet it has no effect on
proliferation of Mash1
þ or Sox2
þ cells. In vivo, the increase in
neuronal number observed in Gdf11
 /  mice is accompanied
by an increase in INPs, but not in Mash1
þor Sox2
þcells. These
data imply that GDF11 regulates tissue size by inhibiting the
proliferation of a committed transit-amplifying cell.
Because GDF11 can slow and even arrest INP divisions, it is
natural to model GDF11-mediated negative feedback as an
increase in the cell-cycle length of the INP (Figure 3B).
Indeed, there is abundant literature showing that GDF11,
GDF8, and other TGFb superfamily members slow rates of
progression through the cell cycle, at least in part by inducing
cyclin-dependent kinase inhibitors [34,41–44]. Increasing the
INP cell-cycle length is equivalent to decreasing its v-
parameter, v1 (Figure 3B). Unfortunately, the result in Figure
2C states that the steady state outputs of lineage systems are
independent of all v except for that of the stem cell (v0). This
makes intuitive sense: if one decreases the division rate of an
intermediate-stage cell in a lineage, the unchanged inﬂux of
cells from the previous lineage stage will cause its numbers to
rise proportionately. From the standpoint of the lineage
output, the two effects will cancel.
Apparently then, having GDF11 (or any other factor) feed
back onto the INP cell division rate can be of no use in
controlling the steady state level of ORNs. Could such
feedback serve a function related to some other performance
objective, such as rate control? As mentioned earlier, without
control, lineage systems would be expected to return to
steady state after a perturbation (i.e., regenerate) with a time
scale similar to that over which terminal-stage cells normally
turn over. In principle, feedback onto the cell division rate of
a lineage intermediate could improve this. However, as
explained below, the utility of this strategy turns out to be
very limited:
Figure 3C shows a simulated regeneration experiment in
which output, via GDF11, feeds back onto v1. At the start of
the experiment, all ORNs are synchronously destroyed, and
the time course of the return to steady state is followed (this
type of perturbation can be produced experimentally by
transecting the olfactory nerve or removing one or both
olfactory bulbs of the brain [45]). For comparison, the ﬁgure
also shows what the time course of the return to steady state
would be in the absence of feedback (dashed line). From
Figure 3C, we can see that feedback enables the system to
regenerate faster, but we also observe a very high proportion
of INPs (they are virtually as numerous, at steady state, as
ORNs). It turns out that speeding up regeneration requires a
large feedback gain (the parameter h in Figure 3B), which in
turn drives down steady state ORN numbers (relative to other
cells). If we deﬁne progenitor load as the percentage of the
entire tissue that is composed of progenitors (stem cells plus
INPs), we ﬁnd that requiring the steady state progenitor load
to be less than 50% limits any improvement in regeneration
speed to about 3.2-fold; restricting progenitor load to 10%
drops this value to about 2.6-fold (Figures S16 and S17 in
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progenitor load in the OE is below 10% [46–48].
There is another cost of achieving fast regeneration
through feedback on v1: the lower the progenitor load, the
more necessary it becomes to use values of p1 that are
perilously close to 0.5 (i.e., nearly half the output of INPs
needs to be more INPs; Figures S16 and S17 in Protocols S1–
S3). As discussed earlier, when p-parameters are close to 0.5,
system output becomes extremely sensitive to small variations
in those parameters (and thus very fragile).
All told, feeding back onto the rate at which INPs divide
does not seem to be a particularly good control strategy. We
wondered whether GDF11 might do a better job if it fed back
onto a different parameter of INP growth: p1, the replication,
or ampliﬁcation, probability. Analysis of a model of this sort
of feedback (Figure 3D) reveals several remarkable things:
First, with feedback on p1, the constraint p1   0.5 goes
away: Any INP replication probability allows for establish-
ment of a steady state. Second, the fragility of the steady state
output can be substantially reduced. In particular, sensitivity
Figure 3. Strategies for Feedback Regulation of Transit-Amplifying Cells
(A) The neuronal lineage of the OE, in which terminally differentiated ORNs are produced by committed transit-amplifying cells (INPs).
(B) Negative feedback regulation of the INP cell cycle length (shown diagrammatically in red) can be modeled by making v1 a function of ORN numbers
(v2).
(C) Simulated return to steady state of the system in (B) after removal of all ORNs. The parameters chosen provide the greatest improvement in
regeneration speed (over what would occur in the absence of feedback; dashed line), consistent with progenitor cells comprising no more than 50% of
the tissue mass (note that INP numbers [red curve] are virtually the same as those of ORNs [blue curve] at steady state). Cell numbers are expressed
relative to the starting number of stem cells.
(D) Negative feedback regulation of the INP replication probability (shown diagrammatically in red) can be modeled by making p1 a function of ORN
levels (v2).
(E) Simulated return to steady state of the system in (D) after removal of ORNs. An inset shows the response at early times in greater detail. Note that
progenitor load is now quite low, and regeneration is characterized by a burst of INP proliferation (red curve), followed by a wave of ORN production
(blue curve).
In (C and E), time is expressed in units of ln2/v1. Parameter values for (C) are p1¼0.495, d/v1¼0.0372, v0/v1¼0.128, and h¼0.0734, and for (E) are p1¼
0.942, d/v1 ¼ 0.0138, v0/v1 ¼ 0.506, and g ¼ 0.0449.
doi:10.1371/journal.pbio.1000015.g003
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the death rate of terminally differentiated cells can be made
arbitrarily small for appropriate parameter choices. Sensi-
tivity to p1 can also be greatly reduced (to values ,1), even if
p1 is large (Figures S1 and S2 in Protocols S1–S3).
Finally, such a system can mount explosive regeneration
after a perturbation. In some cases, the return to steady state
can be as much as 100 times faster than in the absence of
feedback. Furthermore, this can be accomplished without the
need for a high progenitor load. Figure 3E shows this
behavior for a particularly effective set of parameters. Notice
how, in response to an acute loss of terminal-stage cells
(ORNs), transit-amplifying cells (INPs) undergo a rapid, but
transient, increase in number, following which, terminal-
stage cells are restored rapidly to values close to steady state.
This sort of behavior closely parallels what is seen in the OE
following olfactory bulbectomy (in which ORN degeneration
is induced by olfactory bulb removal): a transient upsurge in
progenitor cell numbers, followed by a wave of neuronal
production [20,40,46,49–51].
GDF11 Controls Replication Probabilities
The fact that feedback aimed at p1 can, in theory, produce
more useful and realistic behaviors than feedback aimed at v1,
raised the possibility that the actual target of GDF11 might be
p1, and not v1, as initially thought. To resolve this issue, we
carried out tissue culture experiments in which mouse OE
progenitor cells were pulse-labeled with 5-bromo-2-deoxyur-
idine (BrdU; to label cells undergoing division), and evaluated
at successive times thereafter to determine when the progeny
of dividing cells acquire immunoreactivity for NCAM, a
marker for terminally differentiated ORNs. As shown
previously, most dividing cells in these cultures are INPs,
and their cell cycle length is about 17 h [39]. If all INP
divisions result in production of ORNs, the acquisition of
NCAM immunoreactivity by all BrdU-labeled cells should
occur after sufﬁcient time to progress through the rest of S-
phase, G2-phase, M-phase, and however long it takes for
NCAM levels to rise above the threshold of detection. If some
INPs replicate, however, then a fraction of labeled cells will
not express NCAM until one cell cycle (;17 h) later (if the
replicating fraction is high enough, some progeny will go
through several cell cycles before acquiring NCAM immu-
noreactivity; cf. [39]). Accordingly, delay in the onset of
NCAM expression can be used as a measure of the INP
replication probability.
Figure 4 shows the effect of GDF11 (added to the culture
medium 12 h prior to BrdU labeling) on acquisition of NCAM
expression by BrdU pulse-labeled cells. In Figure 4J, data for
two different ‘‘chase’’ periods are graphed. In the absence of
GDF11, about 60% of BrdU-labeled cells become NCAM-
positive within 18 h. In the presence of low levels of GDF11,
this percentage rises as high as 75%, then falls again at high
concentrations of GDF11 to less than 10%.
The increase in neuronal differentiation in response to low
levels of GDF11 documents that GDF11 indeed suppresses
INP replication (i.e., it lowers p1). The fact that this increase
gives way to a large decrease in neuronal differentiation at
high GDF11 levels is most likely due to the additional effect of
GDF11 on the rate of cell cycle progression: As the INP cell
cycle is progressively lengthened, one would expect that an
18-h chase period would cease being long enough to allow
BrdU-labeled cells to go on to differentiate. This would lead
to a sharp drop-off in the percentage of BrdU-labeled cells
that acquire NCAM expression, but with longer chase times
(e.g., 36 h), this effect would be overcome. That is indeed what
is observed (Figure 4J). A numerical simulation of the
experiment, in which GDF11 negatively regulates both p1
and v1, replicates both qualitative and quantitative features of
the experimental data (Figure 4K; Protocols S1–S3, section
10).
Performance Tradeoffs
Having the output of the OE lineage feed back onto p1
seems to be an effective strategy for meeting two control
objectives: steady state robustness (low sensitivity to stem cell
number v0, cell division rates v0, and v1, and the death rate
constant of the terminal-stage cell d) and rapid regeneration.
But the ability to meet each objective separately does not
guarantee that both can be met together (i.e., for the same
sets of parameters).
As it turns out, the two strategies are largely incompatible.
Numerical exploration of the parameter space shows a strong
negative correlation between robustness and enhancement of
regeneration (Figure 5A). Cases for which the sensitivity to v0,
v0,o rd is less than 0.4 (i.e., a 2-fold change in parameter will
cause  32% change in output), generally do not exhibit
acceleration in regeneration speed exceeding approximately
8-fold. In fact, this result is skewed by cases in which
regeneration speed goes from extremely slow (in the absence
of feedback) to merely very slow. If one restricts the analysis
to cases in which regeneration from complete loss of
terminal-stage cells is 80% complete in fewer than 29
transit-amplifying cell cycles (;20 d for INPs), then to
achieve parameter sensitivities less than 0.4, the best possible
improvement in regeneration speed is less than 2-fold (Figure
5A and 5B).
Upon closer inspection, other unfortunate tradeoffs can be
seen: For the cases in Figure 5A, improvement in regener-
ation speed was calculated by simulating a complete loss of
terminal-stage cells and then measuring the return to steady
state. If we use a milder perturbation (a 75% loss of terminal-
stage cells), but otherwise the same parameters, the return to
steady state is, unexpectedly, quite slow (Figure 5C). The need
to sustain injury that is massive before regeneration can be
rapid hardly seems like a good strategy for an organism in the
real world. To deﬁne the conditions under which this
phenomenon occurs, we calculated, for all the cases in Figure
5A, the ratio of two regeneration times: the time for
regeneration from a 100% perturbation, and the time for
regeneration from a 75% perturbation. In Figure 5D, this
value (‘‘speed ratio’’) is plotted against fold improvement in
regeneration speed (for the 100% perturbation, compared
with no feedback). The data show that the speed of
regeneration following massive injury cannot be improved
by more than about 3-fold, without sacriﬁcing the speed of
regeneration following less-than-massive injury.
Altogether, tradeoffs among regeneration speed, sensitivity
to parameters, and sensitivity to initial conditions make the
control strategy of having GDF11 feed back onto p1 less
attractive than it originally seemed. Analysis of cases in which
GDF11 inhibits both p1 and v1 (which corresponds most
closely to what GDF11 does in vitro; Figure 4J and 4K) shows
some improvement in the tradeoff between regeneration
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(Figure S18 in Protocols S1–S3). Accordingly, we wondered
whether additional control elements might still be missing.
Two Loops Are Better Than One
As mentioned in Table S1, many feedback inhibitors of
tissue and organ growth belong to the TGFb superfamily of
growth factors, with those of the TGFb/activin branch (which
signals through the intracellular proteins Smad2 and Smad3)
being the most highly represented. Recently, we found that
activinbB( Inhbb; MGI: 96571; hereafter referred to simply as
‘‘activin’’) is highly expressed in the OE and, like GDF11, has
growth-inhibitory effects on the neuronal lineage. Unlike
GDF11, however, activin’s effects are aimed speciﬁcally at the
Sox2
þ and Mash1
þ populations, and not at INPs (K. K.
Gokoffski et al., unpublished data). This implies that two
feedback loops exist in the OE, one aimed at stem cells, and
one aimed at transit-amplifying cells (Figure 5E).
Like GDF11, activin could potentially feed back onto a v-
parameter (namely v0, the rate of stem cell division) or a p-
parameter (namely p0, the stem cell replication probability),
or both. For technical reasons, a pulse-chase experiment
similar to that in Figure 4 cannot be performed to sort this
out. However, we infer that feedback onto p0 must occur,
because Sox2
þ and Mash1
þ populations are markedly ex-
panded in the OE of ActbB
 /  mice (K. K. Gokoffski et al.,
unpublished data). If activin only regulated v0, loss of activin
would result in stem cells that cycle faster, but it could not
increase their numbers.
Interestingly, when we add the feedback effects of both
activin and GDF11 into the equations for the behavior of the
ORN lineage, the expression for the steady state value of
ORNs becomes very simple: (2p0 1)/j, where j is the feedback
gain for activin (Protocols S1–S3, section 4). This constitutes a
dramatic improvement in robustness—the system will, at
steady state, always produce the same number of terminal-
stage cells regardless of how many stem cells it starts with,
how fast stem cells divide, or how quickly terminal-stage cells
are lost.
Perhaps even more strikingly, the problematic constraint
that the stem cell population must intrinsically ‘‘know’’ to
replicate exactly half the time (p0¼0.5) vanishes. As long as p0
. 0.5, feedback automatically ensures that the stem cell
population behaves in the necessary way.
Figure 4. Experimental Demonstration That GDF11 Regulates p1 and v1
OE explants were cultured in various doses of GDF11. At 12 h, BrdU was added for 2 h and then washed out. Explants were fixed at various times after
BrdU addition and immunostained for BrdU and NCAM expression.
(A–I) Cultures grown in GDF11 concentrations of 0 (A, D, and G), 0.5 (B, E, and H), and 10 (C, F, and I) ng/ml, fixed 18 h after BrdU addition (previous
studies have shown that 18 h is sufficient time for INP progeny that become ORNs to express NCAM [39]). NCAM immunofluorescence (green) is shown
in (A–C); BrdU immunofluorescence (red) in (D–F); merged images in (G–I). Arrowheads point to examples of BrdU
þ/NCAM




(J) Percentage of BrdU
þ cells migrating out of OE explants that had differentiated (acquired NCAM immunoreactivity) by 18 h (black line) or 36 h (blue
line), as a function of GDF11 dose. Low doses of GDF11 increase the proportion of INP progeny that differentiate (i.e., p1 decreases). At high dose, the
effect reverses, with the NCAM
þfraction falling to near zero at 18 h, but recovering at 36 h. These data are consistent with a slowing of the cell cycle (v1)
such that 18 h is not long enough to produce NCAM
þ offspring (but 36 h is). This interpretation is consistent with a previous demonstration that high
doses of GDF11 reversibly arrest the INP cell cycle [34].
(K) Simulation of the experiment in (J) by a model in which GDF11 affects both p1 and v1. Parameters used in the model are consistent with measured
proportions of ORNs, INPs, and Mash1
þ/Sox2
þ cells, as well as experimental data on the effects of GDF11 on BrdU pulse-labeling by INPs [34,39,40].
doi:10.1371/journal.pbio.1000015.g004
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solely from the single feedback loop of system output onto p0.
When such a loop is in place, however, feedback onto other p-
and v-parameters can have additional useful effects:
Consider, for example, the matter of regeneration speed,
which we previously found could be increased through
feedback onto p1 or v1, but only by sacriﬁcing robustness,
low progenitor loads, or the ability to regenerate quickly
from a variety of initial conditions (Figures 3C and 5A–5D).
When feedback is directed solely at stem cells, we also fail to
achieve good performance: Feedback onto p0 hardly improves
regeneration speed at all (Figure S19 in Protocols S1–S3), and
although feedback onto p0 and v0 together can produce fast
rates of regeneration (Figure S21 in Protocols S1–S3), those
rates still show a very sensitive dependence on initial
conditions (Figure S22 in Protocols S1–S3).
In contrast, when feedback is directed at both stem and
transit-amplifying cell stages—i.e., the arrangement that
actually occurs in the OE—it becomes possible to achieve
very rapid regeneration, with low progenitor loads, from
almost any starting conditions. This includes conditions in
which variable numbers of stem, transit-amplifying, or
terminal-stage cells are depleted. Figure 5F shows an example
of such a case.
Not only is such performance possible, it occurs over a
substantial fraction of the parameter space (that is, a
Figure 5. Performance Tradeoffs Associated with Feedback Strategies
(A) Simulations of the model in Figure 3D were carried out for 20,000 randomly chosen sets of parameters (Protocols S1–S3, section 8). To simulate
regeneration following a loss of terminal-stage cells, numbers of ORNs were set to zero, whereas numbers of stem cells and transit-amplifying cells
(INPs) were set to their steady state values. For each parameter set, the time it took for ORN numbers to return to and remain within 20% of their steady
state values was taken as an objective measure of regeneration time, and cases with very long regeneration times (.29 transit-amplifying cell cycle
lengths) are not shown (see Protocols S1–S3). Next, the time that would have been required to generate the same number of ORNs, from the same
initial conditions but in the absence of feedback, was calculated. Finally, the ratio of the two regeneration times (with and without feedback) was
considered to be the fold improvement in regeneration speed due to feedback. For each parameter set, this was plotted against the sensitivity of the
steady state solution to variation in either the initial number of stem cells, the stem cell cycle time, or the normal lifetime of ORNs (all three sensitivities
are equal). The data show that only those parameter sets that do not support a robust ORN steady state (abscissa values .0.4) show substantial
improvement in regeneration speed (ordinate values .2).
(B) Simulated regeneration for the set of parameters in (A) that showed the greatest improvement in regeneration consistent with sensitivity to
parameters remaining below 0.4 (this corresponds to a 32% change in steady state values for a 2-fold change in parameters). As in Figure 3, the blue
curve denotes ORN numbers, the red curve shows INPs, and the dashed line shows the time course over which regeneration would proceed in the
absence of feedback. The light-blue zone denotes the range of cell numbers within 20% of the steady state value for ORNs.
(C) Simulated regeneration for the parameters used in Figure 3C, but starting from two different initial conditions. The solid blue curve shows the
dynamics of ORN recovery after complete removal of existing ORNs; the solid gray curve illustrates the predicted rate of recovery in the absence of
feedback. The dashed blue and gray curves present corresponding simulations where ORN numbers were initially depleted only 75%, rather than
completely. Under these conditions, nearly all improvement in regeneration is lost.
(D) To quantify the effect of initial conditions on regeneration speed, a ratio was defined (‘‘speed ratio’’) that indicates how much faster (or slower)
regeneration from 75% ORN depletion is than regeneration from 100% depletion. In the absence of feedback, this ratio should have a value of
approximately 1.22 (regeneration from partial depletion should take slightly less time than regeneration from total depletion). This ratio was calculated
for each of the random cases shown in (A), and the results were plotted against the fold improvement in regeneration speed (from [A]). The abscissa is
drawn at an ordinate value of 1.22. The plot shows that the more one gains in regeneration speed from 100% depletion, the more one sacrifices in
regeneration speed from 75% depletion.
(E) Negative feedback effects of activin and GDF11 (shown diagrammatically in red) can be modeled by multiplying the replication probabilities and cell
division rates of stem cells and INPs, respectively, by decreasing functions of ORN numbers (v2). In this case, Hill functions are used, with parameters g,
h, j, and k representing the feedback gains, and n the Hill coefficient.
(F) Example of a case with both activin and GDF11 feedback. Notice that now, regeneration from initial conditions of 75% ORN depletion is nearly as fast
as regeneration from 100% ORN depletion (compare with [C]). Parameters for this case are: p0¼0.507, p1¼0.546, d/v1¼0.0116, v0/v1¼0.965, g¼1.258,
h ¼ 1.03, j ¼ 0.0394, and k ¼ 1.683 (and the ordinate axis has been scaled for easier comparison with [C]).
In (B), (C), and (F), time is expressed in units of ln2/v1.
doi:10.1371/journal.pbio.1000015.g005
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meet all of these performance objectives). Figure 6A shows
graphically how, as feedback loops are added one at a time,
good control (robustness, stability, low progenitor load, and
fast regeneration from a variety of conditions) is found over
an increasing fraction of the parameter space (exploring wide
ranges on all parameters). In evaluating the magnitude of this
effect, it should be noted that fractions of parameter space in
the range of 0.1%–1.5% are remarkably high, given the
numbers of parameters in each model (cf. [52]). For example,
when there are eight independent parameters (as there are
when feedback is directed at p0, v0, p1,a n dv1), good
performance over 0.1% of the parameter space means that
the average parameter value ‘‘works’’ over 42% (;0.001
1/8)o f
its range. In Figure 6, most parameters were explored over
three orders of magnitude (i.e., they were randomly selected
from a log-uniform distribution with a 1,000-fold range), so
for such cases, 42% means that the average parameter can be
varied over an 18-fold range (1,000
0.42) without loss of good
control.
What is the signiﬁcance of a control system that works over
a large portion of its parameter space? It means that the
output of the system can be adjusted (through changes to the
parameters) without the control strategy itself being jeopar-
dized. From a biological perspective, this means that the
system is evolvable, a feature we should expect to observe in
most biological control systems [53].
Sensitivity and Geometry
So far, we have said much about the cell stages and
processes that are targets for feedback in cell lineages, and
little about the quantitative details of feedback signals. In
Figures 3 and 5, feedback was modeled using Hill functions;
these are natural choices for the actions of secreted growth
factors, since saturable binding of ligands to receptors is
usually well described by them [54].
Hill functions typically employ a parameter n, the Hill
coefﬁcient, to ﬁt dose-response relationships that are
positively (n . 1) or negatively (n , 1) cooperative. In Figures
3, 5, and 6A, a Hill coefﬁcient of 1 was used, but more detailed
exploration of the two-loop feedback system (with feedback
on p0, v0, p1, and v1) shows that system performance increases
Figure 6. Effects of Feedback Configuration on Regeneration from Diverse Perturbations
(A) Four different feedback architectures (shown diagrammatically beneath the word ‘‘Legend’’) were modeled and investigated for their ability to
support rapid regeneration from multiple starting conditions. For each model, 20,000 random parameter sets were explored (see Protocols S1–S3,
section 8) using simulations that started from initial conditions corresponding to four different perturbations of the steady state. For all 640,000
solutions, the fold improvement in ORN regeneration speed was calculated as in Figure 5. The bar graphs depict the fractions of random parameter sets
for each model that produced at least a given amount of improvement in regeneration speed for one or more sets of initial conditions. The four
different feedback architectures are designated by different colored bars (see diagrams under ‘‘Legend’’): feedback on p0 (grey); p0 and v0 (red); p0, v0,
and v1 (green); and p0, v0, p1, and v1 (blue). The heights of bars give the fraction of parameter sets that produced at least the indicated amount—4-fold
(left graph), 6-fold (middle graph), or 8-fold (right graph)—of improvement in regeneration speed. The ‘‘Performance categories’’ refer to different
combinations of initial conditions: Cases included in performance category 1 are those that met the desired level of improvement in the speed of
regeneration following a complete loss of terminal-stage cells. In category 2, the perturbation was a complete loss of both terminal-stage and transit-
amplifying cells. In category 3, it was a 75% loss of terminal-stage cells. In category 4, the perturbation was a complete loss of terminal-stage and transit-
amplifying cells and a 50% loss of stem cells. Category 5 cases are those parameter sets that met the criteria for initial conditions of both categories 1
and 2. Category 6 refers to those that did so for both categories 1 and 3. Category 7 refers to those that did so for both categories 1 and 4. Category 8
refers to cases in which the parameter sets met the indicated criterion for all four initial conditions. The data show that rapid regeneration from a variety
of initial conditions is facilitated by feedback on the p-parameters of at least two progenitor cell stages.
(B and C). For the system with feedback on p0, v0, p1, and v1 (i.e., the system depicted with blue bars in [A]), the graphs show the percentages of random
parameter sets that meet the regeneration-rate criteria on the abscissa (4-fold, 6-fold, or 8-fold improvement in regeneration speed), as a function of the
Hill coefficient, n, used in the expressions for the feedback functions. The results in (B) were obtained by only considering simulations that started from
a 100% loss of terminal-stage cells. Cases presented in (C) are those that also met the same regeneration-rate criteria for simulations starting from a 75%
loss of terminal-stage cells. The results show that larger n substantially increases the fraction of cases with rapid regeneration. This effect is especially
prominent when the performance criteria call for fast regeneration from more than one set of initial conditions (C).
doi:10.1371/journal.pbio.1000015.g006
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intuitive sense if we consider that high values of n make Hill
functions more switch-like. In the limit of a perfect switch
(inﬁnite n), the drive for increased growth would be zero
when output is at the desired value, yet maximal when output
is even slightly below the desired value. Such a strategy clearly
achieves the fastest possible regeneration following a pertur-
bation.
In biology, dose-response relationships that are ﬁt by Hill
coefﬁcients other than 1 arise for a variety of reasons besides
biochemical cooperativity; these include buffering, competi-
tion, feedback, and distributed multistep reactions [55–57].
Generally speaking, Hill coefﬁcients quantify the sensitivity of
output to input (in the limit of high input, the Hill coefﬁcient
and the engineering deﬁnition of sensitivity are equivalent).
Thus, in our models of feedback in the OE, Hill coefﬁcients
near 1 mean that the amount of activin and GDF11 signaling
in stem cells and INPs (respectively) is roughly proportional
(over some range) to the number of cells producing activin
and GDF11 (i.e., the size of the tissue).
It occurred to us that this situation—feedback propor-
tional to tissue size—might not be so easy for tissues to
achieve. As a tissue grows in size, one can certainly envision
the total amount of material it produces increasing propor-
tionally, but it is the concentrations—not the amounts—of
factors like GDF11 and activin to which cells respond. How
the concentrations of secreted ligands change as tissues grow
turns out to depend both on issues of geometry (tissue shape
and boundary properties), and issues of cell biology (rates of
ligand capture and turnover).
For example, consider a hypothetical tissue surrounded by
a boundary across which macromolecules cannot diffuse. In
this case, a secreted protein produced everywhere in the
tissue should reach a steady state concentration determined
by the balance between production and local degradation. If
the tissue doubles in size, it will make twice as much of the
protein, but distribute it over twice the volume. The result
will be no change in concentration. In a truly ‘‘closed’’ tissue,
secreted molecules cannot be used as part of a strategy for
growth control.
Fortunately, epithelia, such as the OE, are not closed
systems. Although tight junctions between epithelial cells
prevent escape of molecules from the apical surface, there
appears to be little or no impediment to diffusion across a
basal lamina into the underlying connective tissue stroma
[58]. Within such a geometry, we may use approaches
developed for the analysis of morphogen and signaling
gradients [59–62] to calculate expected intraepithelial dis-
tributions of secreted molecules (Protocols S1–S3, section 11).
The results of these calculations (Figure 7) show that when
an epithelium is very thin, concentrations of secreted
molecules in the intercellular space initially go up linearly
with tissue size, but soon level off. Does the normal size range
of the OE (adult thickness ;80 lm) lie in the linear region, or
on the plateau? The answer depends on two factors: The ﬁrst
is the decay length of the molecule of interest. This is the
average distance a molecule travels in tissue before being
captured and degraded by cells, and is a function of its
diffusion coefﬁcient and rate of receptor-binding and
degradation.
The second factor is the ratio of decay length within the
epithelium to decay length in the adjacent stroma (which, in
most cases, simply reﬂects how much faster or slower
degradation proceeds in one location versus the other). If
that ratio is low—i.e., if molecules that diffuse into the stroma
are not quickly degraded—then intraepithelial concentra-
tions will be poorly sensitive to tissue size long before the
epithelium reaches even a single decay length in thickness
(Figure 7A; Figure S27 in Protocols S1–S3).
In contrast, if the ratio of decay lengths between
epithelium and stroma is high—i.e., if the stroma acts as a
sink, quickly eliminating molecules that enter it—then
average intraepithelial concentrations will rise more gradu-
ally, and not plateau until the epithelium has reached a size of
several decay lengths (Figure 7B). This effect is more
pronounced if the concentration that matters is the concen-
tration close to the basal surface of the epithelium, and not
the average concentration over the entire epithelial thick-
ness. At this basal location, concentration varies linearly with
tissue size for many decay lengths (Figure 7B; Figure S28 in
Protocols S1–S3).
Estimates of intraepithelial decay lengths of TGFb super-
family polypeptides, obtained both from measurements of
morphogen gradients and from ﬁrst-principles calculations,
tend to be in the range of tens of micrometers [59,63–65], i.e.,
on the order of, or less than, the normal thickness of the OE.
This suggests that it would be difﬁcult to use activin and
GDF11 as ‘‘reporters’’ of OE size, if these molecules merely
leaked into the stroma and were not rapidly degraded there
(as in Figure 7A): once the OE grew beyond 0.2 decay lengths
in thickness, the poor sensitivity of activin and GDF11
concentrations to OE size would be functionally equivalent
to feedback described by Hill coefﬁcients less than 0.5. As
already demonstrated (Figure 6B), such low Hill coefﬁcients
undermine good control.
Accordingly, we infer that it would be strategically
advantageous for the OE to possess a mechanism that rapidly
removes activin and GDF11 in the underlying stroma, as well
as a mechanism for restricting the location at which cells
measure the level of activin and GDF11, to the basal surface
of the tissue. Remarkably, the OE seems to have both:
First, the OE contains large amounts of the protein
follistatin (FST; MGI: 95586) in its basement membrane and
stroma (Figure 7C; [34,66]). FST not only binds and inhibits
both activins and GDF11, it does so irreversibly, effectively
eliminating them [67–69]. That FST plays a central role in
regulating GDF11 and activin function in the OE has recently
been demonstrated genetically ([34] and K. K. Gokoffski et al.,
unpublished data); what the analysis here provides is an
explanation for why FST is used by the OE, and why it should
be found primarily beneath the epithelium.
Second, the progenitor cells of the OE that respond to
activin and GDF11 become increasingly polarized, during
early development, to the basal side of the epithelium;
eventually they lie within a few cell diameters of the basement
membrane. This is shown in Figure 7D and 7E, using in situ
hybridization for Ngn1 to visualize INPs. Thus, the only
concentrations of GDF11 and activin that progenitor cells
sense are likely to be those near the basal surface of the
epithelium. Interestingly, in many other types of epithelia,
stem/progenitor cells also localize near the basement mem-
brane, an observation that has long suggested the existence of
a specialized microenvironment, or ‘‘niche,’’ in this region
[70].
PLoS Biology | www.plosbiology.org January 2009 | Volume 7 | Issue 1 | e1000015 0093
Cell Lineages and Proliferative ControlFinal-State Systems
The OE, a self-renewing tissue, maintains its size by
continuous replacement of dying cells [51,71]. Some or-
gans—such as the mammalian brain—achieve a ﬁnal size
during development and largely cease proliferating [72–74].
Such ﬁnal-state (as opposed to steady state) systems also may
be modeled using the equations in Figure 2, by setting the
terminal cell death rate constant, d, to zero, and allowing
replication probabilities to be below 0.5. Like steady state
systems, they can be quite fragile.
This point is well illustrated by the mouse brain, which is
composed of approximately 10
8 cells of neural lineage
(neurons and glia; [16]). Although brain cell number varies
from mouse to mouse, within a given strain, the coefﬁcient of
variation is small, about 5% [16]. If we hypothesize that the
brain is ‘‘founded’’ by a pool of 10
5 progenitors (probably an
overestimate), and we make the simplifying assumption that
no cells die during development, then a 1,000-fold expansion
in cell numbers is needed (Figure 8). One way to accomplish
this would be to have all progenitors replicate for a time
equal to ten cell-cycle lengths (2
10 ¼ 1,024), and then stop.
With this strategy, ﬁnal cell number will be linearly sensitive
(i.e., proportional) to the initial size of the progenitor pool
(Figure 8A), and much more than linearly sensitive to the
average length of the cell cycle, or the length of time allowed
for proliferation (a mere 5% change in either parameter
would produce a 30% change in output). If the brain is
founded by fewer progenitors, this fragility only becomes
more severe.
Now, let us consider a slightly more sophisticated strategy:
a progenitor pool that undergoes a mixture of replicative and
differentiative divisions, with a replication probability p set
below 0.5. Because proliferating cells replicate less than half
the time, the progenitor pool runs out, and the tissue
Figure 7. Effects of Geometry and Degradation on Levels of Secreted Molecules within Epithelia
(A and B) Polypeptides secreted into the intercellular space of an epithelium are removed by two processes: diffusion into underlying connective tissue
(stroma) and degradation within the epithelium. Given a molecule’s rate of production, its diffusivity, its rate of uptake and degradation, and the
geometry of the epithelium, one may calculate its concentration, at steady state, at every location within the epithelium. Here, such calculations are
shown graphically, for epithelia of different thicknesses (in each picture, the epithelium is oriented with the apical surface at the top). Epithelial
thickness (‘‘height’’) is scaled according to the decay length of the molecule of interest. The shading in each picture depicts the concentration of the
secreted molecule, with black representing the limiting concentration that would be achieved in an epithelium of infinite thickness. In (A), the
degradation capacity of the stroma is set at a relatively low value, one-tenth of that in the epithelium. In this case, intraepithelial concentrationso f
secreted molecules plateau while the epithelium is very thin. In (B), the degradation capacity of the stroma is ten times of that in the epithelium, so that
few molecules that enter the stroma escape undegraded. Now, there is a large (and more physiological) range of epithelial thickness over which the
concentrations of secreted molecules change appreciably with tissue size. This is particularly true near the basal surface of the epithelium (see also
Figures S27 and S28 in Protocols S1–S3).
(C) Follistatin (FST), a molecule that binds GDF11 and activin essentially irreversibly, is present at high levels in the basal lamina (arrow) and stroma
(asterisk) beneath the embryonic day 13 OE. Association of FST with basal laminae is consistent with its affinity for extracellular matrix components
[102]. Scale bar represents 100 lm.
(D and E) INPs (visualized with Ngn1 in situ hybridization) become progressively localized to the basal surface of the OE over the course of development.
(D) ¼ embryonic day 12.5; (E) ¼ embryonic day 18.5. nc ¼ nasal cavity. Scale bar in (E) represents 100 lm.
doi:10.1371/journal.pbio.1000015.g007
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cycles or time. In this case, the ﬁnal state is still linearly
sensitive to the initial size of the progenitor pool, and
although no longer sensitive to time or cell-cycle parameters,
it is extremely sensitive to the value of p itself, which must be
very close to 0.5 to produce a 1,000-fold expansion in cell
numbers (Protocols S1–S3, section 5).
One way to circumvent this extreme fragility is to allow p to
change over time, starting above 0.5 (promoting progenitor
expansion), then falling below 0.5 (driving progenitor cell
extinction). In fact, this very mechanism, illustrated in Figure
8B, was introduced by Nowakowski et al. [75] to explain the
biphasic expansion and contraction of progenitor pools in
the cerebral cortex, and it is supported by considerable
experimental data (e.g., [76]). Mathematical analysis (Proto-
cols S1–S3, section 5) shows that sensitivity to p is reduced by
this strategy, but it still remains very high (Figure S5 in
Protocols S1–S3). Moreover, the system now becomes quite
sensitive to the rate at which p declines (relative to the cell-
cycle length; Figure S4 in Protocols S1–S3). In addition, such
a system is still linearly sensitive to the initial size of the
progenitor pool (Figure 8B).
Given how difﬁcult it seems to be to achieve even modestly
robust ﬁnal states, it is striking how much can be accom-
plished with the addition of just a single feedback loop.
Figure 8C illustrates a case much like the one in Figure 8B, in
Figure 8. Behaviors of Final-State Systems
Three different ways are shown by which an initial pool of 10
5 progenitors (solid curves) or 5 3 10
4 progenitors (dashed curves) can generate 10
8
terminally differentiated cells. Differences among the three mechanisms are illustrated by the diagrams at right.
(A) Simple exponential expansion. The progenitor pool expands for just enough time to produce the desired output and then stops. Halving the
starting number of progenitors halves the output.
(B) Nowakowski-Caviness system: progenitors undergo both replicative and differentiative divisions, according to a replication probability p0, which
starts at pmax . 0.5 and declines linearly to pmin , 0.5 at time s. As in (A), halving the initial progenitor cell number halves the output. The output is also
highly sensitive to values of pmax and s.
(C) System with negative feedback on p0. Feedback is modeled as previously, using a Hill function (without cooperativity in this example). Halving the
starting progenitor pool now produces almost no change in output (there is, however, a one cell cycle lag in reaching the final state). Sensitivity to p0 is
also reduced.
In each panel, time is expressed in units of ln2/v1. Parameter values were, in (A), time of cessation of cell division¼6.91/v0; in (B), pmax¼1, pmin¼0, and s
¼ 19.4; and in (C), p0 ¼ 0.9, and c ¼ 3.14 3 10
8 (where c is the feedback gain).
doi:10.1371/journal.pbio.1000015.g008
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this time, the decline is caused by feedback from terminal-
stage cells. Superﬁcially (that is, when not perturbed), it
behaves just like the Nowakowski-Caviness model [75],
displaying expansion, contraction, and disappearance of a
stem cell pool. Yet in this case, a 2-fold change in the initial
number of stem cells produces only a minute (0.14%) change
in the ﬁnal state! Even sensitivity to the initial value of p can
be much lower (,5) than in the case without feedback
(Figures S6–S11 in Protocols S1–S3). Just as with our analysis
of steady state systems, this sort of behavior arises only when
feedback regulates replication probabilities (p-parameters),
and not when it regulates cell cycle lengths (v-parameters).
Discussion
At the start of this article, it was argued that, compared
with other biological pathways, cell lineages should be
especially fragile to intrinsic variability and external pertur-
bation. Yet for many tissues and organs, size, growth rate, and
cellular composition are actively maintained within narrow
limits. The goal of the present study was to identify basic
strategies that enable lineage pathways to achieve tight
control of growth. The mammalian OE provided a platform
for pursuing this investigation, which exploited both model-
ing and experimentation. Because some conclusions—those
having to do with distributions of possible regeneration
speeds—were supported by the computational exploration of
parameter spaces, and not derived from models analytically,
it is formally possible that additional system behaviors
relevant to these conclusions were missed. However, given
the large parameter ranges used, the smoothness of the
feedback functions, and the regularity of the solutions (cf.
[77]), this seems unlikely.
The Power of p
Using this approach, we showed that a feedback conﬁg-
uration that exists in the OE—with regulation at two
sequential lineage stages—achieves a variety of important
control objectives, including limited parameter constraints,
decreased parameter sensitivities, improved regeneration
speed, minimized inﬂuences of initial conditions, and
evolvability. The core of this strategy is feedback inhibition
of replication probabilities, referred to here as p-parameters.
Such feedback is highly useful, not only to tissues that
continuously turn over (such as the OE), but also to tissues
that are generated during a discrete period by a transient
pool of progenitors (such as the mammalian brain). In
contrast, feedback on rates of cell division was found to be
of only marginal value unless also combined with feedback
on p.
The data in Figure 4 provide experimental veriﬁcation that
GDF11 in fact acts by lowering the replication probability of
neuronal transit-amplifying cells. Recent work suggests that
GDF8/myostatin works similarly in muscle—lowering the
probability that progenitors replicate and increasing the
probability that they differentiate [78]. Thus, action on p may
be a common feature of feedback inhibitors of tissue and
organ growth. The molecular mechanisms by which such an
action is achieved are currently unknown. Like many
members of the TGFb superfamily, GDF11 and GDF8 up-
regulate the expression of cyclin-dependent kinase inhibitors
(e.g., p21
cip1/waf1, p27
kip1), which are implicated in both
inhibiting cell-cycle progression and promoting differentia-
tion (e.g., [34,41,78–80]). Formally, it is possible that these two
effects are linked, i.e., the probability that a cell replicates or
differentiates is determined by how long its cell cycle lasts.
Indeed, in the developing mammalian brain, an observed
progressive decline in p-values is matched by a progressive
increase in cell cycle lengths [73,76].
However, we do not favor the interpretation that cell cycle
length dictates replication probability, for two reasons. First,
as implied by Figure 4F and 4G (and unpublished data), the
dose of GDF11 needed to maximally decrease p1 in the OE is
considerably lower than that needed to prolong the cell cycle.
Second, several growth factors are known to increase
replication probabilities without altering cell cycle parame-
ters. For example, the FGFs act in this way both on neural
progenitors [39,81] (including the INPs of the OE) and on
muscle progenitors [82]. The inhibitory effects of leukemia
inhibitory factor on mouse embryonic stem cell differ-
entiation also occur without changes to cell cycle parameters
[83]. From this, we conclude that it is at least possible for p-
and v-parameters to be regulated independently.
Strategies of Control: Human versus Biological
In engineering, feedback control is often classiﬁed by the
relationship between a measured ‘‘error’’—usually the differ-
ence between actual and desired output values—and a
control signal, i.e., a quantity that is fed back. ‘‘Proportional
control’’ means the control signal is proportional to the
error. In ‘‘integral control,’’ the signal is proportional to the
integral, over time, of the error. ‘‘Derivative control’’ implies
a control signal proportional to the derivative, with respect to
time, of the error.
Each strategy has strengths and weaknesses, and engineers
often combine them. Proportional control, for example, can
never fully compensate for a steady perturbation, because
only when output is not at the desired level does a non-zero
control signal exist. Proportional control can decrease a
system’s response time, but at the expense of gain (the
amount of ampliﬁcation from input to output). In the lineage
pathways described here, feedback onto v-parameters clearly
exhibits the hallmarks of proportional control: Feedback
onto v0 can reduce, but never eliminate, parameter sensitiv-
ities; and feedback onto v1 can speed regeneration, but only
by decreasing the ratio of terminal-stage cells to progenitors.
Integral control, in contrast, will fully compensate for a
steady perturbation, producing a steady state that is
completely independent of many external and internal
inﬂuences; this phenomenon is sometimes referred to as
‘‘perfect adaptation’’ [84]. Integral feedback also tends to
speed the rate of approach to steady state, but often at the
risk of overshoots, undershoots, and oscillations. In the
lineage pathways described here, feedback onto p0 exhibits
the hallmarks of integral control: output that is independent
of many parameters, very rapid regeneration, and a tendency
toward oscillation (the latter behavior is described in detail in
[77]). To understand how feedback onto p0 implements
integral control, it sufﬁces to note that any steady deviation
in the replication probability of stem cells above (or below)
0.5 leads to an ever-increasing (or ever-decreasing) effect on
system output. In this way, output naturally follows the time
integral of the difference between the effective value of p0
PLoS Biology | www.plosbiology.org January 2009 | Volume 7 | Issue 1 | e1000015 0096
Cell Lineages and Proliferative Control(i.e., p0 as modiﬁed by feedback) and the value 0.5. Feeding
back output onto p0 thus represents true integral feedback
control.
Derivative control is often used by engineers to suppress
instabilities associated with integral control, but it suffers
from its own problems, such as a tendency to amplify noise.
At this point, it is unclear whether derivative control is used
in lineage pathways. Intriguingly, it has been noticed in the
OE that the expression of GDF11 is stronger in immature
than mature cells [34], raising the possibility that GDF11
levels could track, at least to some degree, the rate of change
(i.e., the time-derivative) of system output, and not just the
current output.
To Stem or Not to Stem?
In the biological literature, a sharp distinction between
stem cells and transit-amplifying cells is classically drawn: the
former are said to divide indeﬁnitely and asymmetrically,
regenerating themselves with each division, whereas the latter
are said to have only limited capacity for self-replication
[85,86]. The results of the present study lead us to question
whether stem and transit-amplifying cells necessarily exist. By
this we mean it is possible to have lineages in which all cells
have the same intrinsic proliferative tendencies, yet typical
stem and transit-amplifying behaviors are observed, solely as a
consequence of feedback control. The only conditions
required for this to happen are (1) cells should have an
intrinsic tendency to self-replicate more than half the time (p
. 0.5), and (2) the output of the lineage should negatively
regulate replication probabilities (feedback on p).
For example, in a lineage with two sequential stages of
dividing cells, if the output feeds back onto the p-parameters
of both cell types, then either of two steady states is possible,
depending on the relative strength of the two feedback loops
(see Protocols S1–S3, section 4). In one of these, the ﬁrst cell
stage exhibits classic stem cell behavior, i.e., its population
self-replicates exactly half the time, and the second cell
exhibits classic transit-amplifying behavior, i.e., its popula-
tion appears to undergo limited divisions. In the other, the
ﬁrst cell stage is extinguished, and the second cell exhibits
stem cell behavior (see [77] and Protocols S1–S3, section 4, for
further discussion; see also the related discussion in [87]).
Which cell becomes the stem cell is thus determined by the
feedback, and not anything intrinsic to that cell.
It is easy to see how other typical behaviors of stem cell
systems can also be the consequences of control. For example,
with sufﬁciently large negative feedback onto v-parameters,
progenitor cell populations will appear ‘‘slowly cycling’’ or
even ‘‘resting,’’ and would be observed to be ‘‘label-retaining’’
(see Protocols S1–S3, section 7, especially Figure S13). These
arguments lend strong quantitative support to a view that has
been gathering increasing support, namely that the deﬁnition
of stem cell should be seen as one of context and condition,
not of cell type [6,88,89]. The work presented here addition-
ally suggests that much the same thing could be said about
transit-amplifying cells. Interestingly, recent work on epi-
dermis has shown that cells long thought to be classical
transit-amplifying cells in fact do not display the seemingly
essential property of limited self-replication [30,90]; instead
they behave in a probabilistic manner that is fully consistent
with the models presented here.
No Free Lunch
In engineering, it is widely accepted that one cannot make
a device robust in every possible way to every possible
perturbation. Usually, strategies that eliminate one fragility
come at the expense of creating new ones, a phenomenon
underlying the characteristic ‘‘robust-yet-fragile’’ architec-
ture of highly engineered systems [91,92]. Evidence for such
tradeoffs can be seen in some of the data presented in this
study (for example, the fact that feedback onto p1 leads to
rapid regeneration only at the expense of steady state
robustness; Figure 5B). This suggests that even the two-loop
OE feedback control system of Figure 5E must have an
Achilles’ heel somewhere, and indeed this is the case. For such
a system to robustly control output, the feedback gain
parameters (the relationship between ORN number and the
amount of feedback) must be reliable. In essence, sensitivity
to one set of parameters (stem cell number, growth rates,
death rates, etc.) has been shifted onto another.
Does this mean the control strategy is a failure? Not at all.
As engineers know, control is not about eliminating fragility,
but managing it. One seeks to transfer fragility to parameters
or inputs that are either intrinsically more reliable, or can
themselves be controlled by other means, or to outputs in
which error is more tolerable. The feedback mechanisms
described in the present study end up transferring fragility
from cell-intrinsic processes (cell cycle length and death rate)
to cell-extrinsic quantities (the level of GDF11 or activin in
the extracellular space). This creates an opportunity for
additional regulation, as well as opportunities to tie the
behavior of cells in the OE neuronal lineage to each other, to
other phenomena in the tissue, or even to the behaviors of
cells in surrounding tissues. From a systems biology perspec-
tive, the present study has deﬁned a control module, whose
function can be appreciated in isolation, but whose real
utility depends on how it integrates with other modules.
From Models to Insights
The notion that elements like GDF11, activin, FST, lineage
stages, and epithelial architecture are components of an
integrated system for controlling growth and regeneration
emerges here mainly from the mathematical analysis and
computational exploration of models. The models are ﬁrmly
anchored in experimental data, but their primary use was not
to generate experimental predictions (although such things
did occur, e.g., Figure 4). ‘‘Predictive’’ modeling can be
valuable for testing mechanistic hypotheses, but it often
requires a relatively complete picture of a system’s compo-
nents [64,93]. In tissue and organ growth control systems, it is
indeed likely that components not considered here—such as
Notch and Wnt signaling [94–98], lineage branch points, and
other feedback and feedforward factors—also play important
roles.
Rather, modeling was used here for its explanatory power,
i.e., as a way to achieve clarity in the face of complexity.
Whether the precise control mechanisms suggested here are
‘‘right’’ or ‘‘wrong’’ is less important than the fact that they
provide a more satisfying set of explanations than those
yielded by traditional intuitive reasoning about the data. In
the OE, for example, traditional pathway-centered reason-
ing—following from the analysis of phenotypes—would
naturally emphasize the fact that GDF11 and activin are
potentially redundant ‘‘antineurogenic’’ factors; that Fst is
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by a balance among these factors. Although not inaccurate,
this view draws attention away from what may be more
fundamental relationships: that Fst extends the dynamic
range over which tissue size can be sensed; that GDF11 and
activin regulate a cell-fate decision (to replicate or differ-
entiate); and that stem and transit-amplifying cell behaviors
can be simple consequences of feedback. Such relationships
ﬁt better into the context of observations that Fst is highly
expressed adjacent to several other epithelia that respond to
Fst-sensitive ligands (e.g., in tongue, eye, and gut [66]; that
GDF11 and GDF8 affect other kinds of cell fate decisions (e.g.,
in retina and muscle [99,100]); and that stem and transit-
amplifying cell behaviors are strongly context-dependent in
many lineage systems [6,89,90,101].
Materials and Methods
OE explant culture and labeling. OE explants were prepared as
previously described [39] and cultured with 10 ng/ml recombinant
FGF2 and varying concentrations of GDF11 (PeproTech). After 18 h,
bromodeoxyuridine (BrdU) cell-labeling reagent was added at
1:10,000 (#RPN201; Amersham). Two hours later, explants were
washed with cold thymidine (10 lm; Sigma-Aldrich), growth factors
replenished, and cultures grown for either 16 or 34 h longer (total
culture time was either 30 or 48 h). For 48-h cultures, FGF2 and
GDF11 were refreshed after 40 h in vitro.
Explants were ﬁxed and stained with rat monoclonal anti-NCAM
H28 and mouse monoclonal anti-BrdU antibody as described [39].
Immunoreactivity was visualized with Cy2-Donkey anti-rat IgG (1:50;
Jackson Immunoresearch) and Texas Red goat anti-mouse IgG1 (1:50;
Jackson Immunoresearch). To compare the percentage of ORNs
produced by INPs in each culture condition, total migratory BrdU
þ
cells were counted in at least 15 ﬁelds each of duplicate cultures per
condition and scored for BrdU and NCAM immunoﬂuorescence by
an experimenter blind to the treatment condition, to ensure lack of
bias.
Immunohistochemistry and in situ hybridization to tissue sections.
Embryos were dissected in room temperature phosphate-buffered
saline (PBS; pH 7.2) and heads ﬁxed in 4% paraformaldehyde in PBS
overnight at 4 8C, then cryoprotected, embedded, sectioned, and
processed as described [34]. For Ngn1 in situ hybridization, tissue was
processed using digoxigenin-labeled cRNA probes [34]. FST immu-
nostaining was performed using R&D Systems goat anti-human FST
antibody (10 lg/ml ﬁnal concentration) and visualized with biotiny-
lated horse anti-goat IgG (1:250) in combination with Vector MOM
Immunodetection Kit (PK-2200; Vector Labs) according to the
manufacturer’s instructions.
Computational methods. Mathematical analysis and numerical
simulation were carried out with the assistance of Mathematica
(Wolfram Research). Codes used for all cases shown are provided in
Protocols S1–S3.
Accession numbers. Gene accession numbers used in the manu-
script refer to the Mouse Genome Informatics database, http://www.
informatics.jax.org/.
Supporting Information
Protocol S1. Mathematical Appendix
File includes Figures S1–S31.
Section 1: ODE model of an unbranched lineage.
Section 2: Steady state solution in the absence of feedback.
Section 3: Steady state solution for a two-stage lineage with feedback.
Section 4: Steady state solution for a three-stage lineage with
feedback (Figures S1–S3).
Section 5: Final-state solutions in the absence of feedback (Figures S4
and S5).
Section 6: Final-state solutions in the presence of feedback (Figures
S6–S11).
Section 7: Time-dependent solutions (Figures S12 and S13).
Section 8: Parameter space exploration—methods.
Section 9: Parameter space exploration—supplemental results
(Figures S14–S22).
Section 10: Simulation of pulse-chase experiment (Figure S23).
Section 11: Spatial dynamics calculations (Figures S24–S31).
Section 12: Parameters: deﬁnitions, ranges, and justiﬁcations.
Found at doi:10.1371/journal.pbio.1000015.sd001 (1.59 MB PDF).
Protocol S2. Mathematical Appendix, Mathematica Notebook Ver-
sion
This is a version of Protocol S1 that may be opened as an interactive
ﬁle in Mathematica.
Found at doi:10.1371/journal.pbio.1000015.sd002 (4.06 MB TXT).
Protocol S3. Mathematical Appendix, Mathematica Playere Version
This is a version of Protocol S1 that may be opened as an interactive
ﬁle using Mathematica Player freeware, which is available at http://
www.wolfram.com/products/player/.
Found at doi:10.1371/journal.pbio.1000015.sd003 (4.08 MB TXT).
Table S1. Negative Feedback Regulators of Proliferation
Found at doi:10.1371/journal.pbio.1000015.st001 (104 KB DOC).
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